Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

François-Xavier Maquart

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Biologie Aujourd'Hui|July 6, 2019
François Xavier Maquart
Bulletin De L'Academie Nationale De Medecine|December 22, 2010
[Anti-tumoral matrikines: potential interest in oncology]François-Xavier Maquart
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 31, 2003
Proteolyzed matrix as a template for the regulation of tumor progressionWilliam Hornebeck, François Xavier Maquart
Advances in Pharmacology (San Diego, Calif.)|January 24, 2007
Chondroitin sulfate proteoglycans in tumor progressionYanusz Wegrowski, François-Xavier Maquart
Biologie Aujourd'Hui|July 4, 2012
[50 years of connective tissue research: from the French Connective Tissue Club to the French Society of Extracellular Matrix Biology]François-Xavier Maquart, Jacques-Paul Borel
Annales De Biologie Clinique|May 9, 2012
[Recommendations for the management of monoclonal gammopathies in biochemistry]Jean-Baptiste Oudart, François-Xavier Maquart, Laurent Ramont
Journal De La Societe De Biologie|July 19, 2003
[Proteolysis directed by the extracellular matrix]William Hornebeck, Hervé Emonard, François-Xavier Maquart, et al.
The FEBS Journal|February 27, 2013
Lumican effects in the control of tumour progression and their links with metalloproteinases and integrinsStéphane Brézillon, Katarzyna Pietraszek, François-Xavier Maquart, et al.
Clinical Chemistry|December 1, 2016
Unexpected Creatinine ValuesJean-Baptiste Oudart, Imad Dali Braham, François-Xavier Maquart
Journal De La Societe De Biologie|July 19, 2003
[Biological effects of collagen I and IV peptides]Sylvie Pasco, Laurent Ramont, François-Xavier Maquart, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Biologie Aujourd'Hui|July 6, 2019
François Xavier Maquart
Bulletin De L'Academie Nationale De Medecine|December 22, 2010
[Anti-tumoral matrikines: potential interest in oncology]François-Xavier Maquart
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 31, 2003
Proteolyzed matrix as a template for the regulation of tumor progressionWilliam Hornebeck, François Xavier Maquart
Advances in Pharmacology (San Diego, Calif.)|January 24, 2007
Chondroitin sulfate proteoglycans in tumor progressionYanusz Wegrowski, François-Xavier Maquart
Biologie Aujourd'Hui|July 4, 2012
[50 years of connective tissue research: from the French Connective Tissue Club to the French Society of Extracellular Matrix Biology]François-Xavier Maquart, Jacques-Paul Borel
Annales De Biologie Clinique|May 9, 2012
[Recommendations for the management of monoclonal gammopathies in biochemistry]Jean-Baptiste Oudart, François-Xavier Maquart, Laurent Ramont
Journal De La Societe De Biologie|July 19, 2003
[Proteolysis directed by the extracellular matrix]William Hornebeck, Hervé Emonard, François-Xavier Maquart, et al.
The FEBS Journal|February 27, 2013
Lumican effects in the control of tumour progression and their links with metalloproteinases and integrinsStéphane Brézillon, Katarzyna Pietraszek, François-Xavier Maquart, et al.
Clinical Chemistry|December 1, 2016
Unexpected Creatinine ValuesJean-Baptiste Oudart, Imad Dali Braham, François-Xavier Maquart
Journal De La Societe De Biologie|July 19, 2003
[Biological effects of collagen I and IV peptides]Sylvie Pasco, Laurent Ramont, François-Xavier Maquart, et al.
Pageof 8